Emergent BioSolutions Inc. (EBS) Deep Dive Video

Summary

Emergent is rebuilding into a lean, U.S.-anchored biodefense “national infrastructure” business—undervalued if contracts hold, but exposed to politics, cGMP execution, and NARCAN generic erosion.

View EBS stock page · Read the EBS research report

Loading the video player…